Aptose Biosciences (APTO) Reports Q1 Loss of $0.23
Get Alerts APTO Hot Sheet
Join SI Premium – FREE
Aptose Biosciences (NASDAQ: APTO) reported Q1 EPS of ($0.23), versus ($0.19) reported last year. Revenue for the quarter came in at $3.14 million, versus $1.74 million reported last year.
For earnings history and earnings-related data on Aptose Biosciences (APTO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share